Lifecore Biomedical Reports Financial Results
LFCR•Second-quarter results and guidance
- Lifecore Biomedical, Inc. reported financial results for the second quarter ended June 30, 2026, and provided a corporate update.
- Q2 2026 revenues were $34.20 million, down 6.2% from the prior year.
- The company reaffirmed revenue and adjusted EBITDA guidance for calendar year 2026.
